Cyrus Yang

CEO
Taiwan Bio Therapeutics INC.

​

Dr. Cyrus Yang is a seasoned biotech entrepreneur and visionary executive with a proven track record in venture creation, strategic planning, corporate development, and innovation in cell and gene therapy (CGT). He currently serves as CEO of Taiwan Bio Therapeutics, where he has led the company’s transformation into a global CGT ecosystem builder and redefined the commercialization model for advanced therapies. He pioneered the concept of “Therapeutics Design and Manufacturing” (TDM), a novel framework aimed at revolutionizing CGT process and assay development.
 
Under his leadership, Taiwan Bio has achieved more than a tenfold increase in revenue and closed several high-profile fundraising rounds. In 2024, Cyrus was ranked No. 1 among the Best Biotech CEOs in Taiwan.
 
Prior to this role, he held leadership positions across multiple startups, including founding MiraqueJ Inc. and Popticlear Inc. Dr. Yang holds a DPhil in Molecular and Cellular Medicine from the University of Oxford.

 

Speech title & Synopsis

Industry Perspective: Polyclonal Regulatory T Cell Therapy in Solid Organ Transplantation Clinical Trials

.